Long-term effects of high-intensity resistance and endurance exercise on plasma leptin and ghrelin in overweight individuals: the RESOLVE Study.


Journal

Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme
ISSN: 1715-5320
Titre abrégé: Appl Physiol Nutr Metab
Pays: Canada
ID NLM: 101264333

Informations de publication

Date de publication:
Nov 2019
Historique:
pubmed: 16 3 2019
medline: 17 3 2020
entrez: 16 3 2019
Statut: ppublish

Résumé

The objective of this study was to evaluate the effects of high-intensity resistance and endurance exercise on body composition and plasma leptin and ghrelin concentrations in overweight individuals. One hundred participants were randomly assigned to 3 exercise interventions: high-resistance-low-aerobic exercise (Re), low-resistance-high-aerobic exercise (rE), low-resistance-low-aerobic exercise (re). Interventions began with 3 weeks of residential supervision (phase 1) after which participants had to manage the physical activity programs individually (phase 2). Body composition and plasma variables were measured at baseline and after phase 1 as well as after 3, 6, and 12 months. Significant decreases in body weight and fat were observed after phase 1 (

Identifiants

pubmed: 30875481
doi: 10.1139/apnm-2019-0019
doi:

Substances chimiques

Ghrelin 0
Leptin 0

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

1172-1179

Auteurs

Angelo Tremblay (A)

Institute of Nutrition and Functional Foods (INAF), Université Laval, Québec, QC G0A 4V0, Canada.
Department of Kinesiology, Université Laval, Québec, QC G0A 4V0, Canada.

Frédéric Dutheil (F)

CNRS, LaPSCo, Physiological and Psychosocial Stress, University Hospital of Clermont-Ferrand, CHU Clermont-Ferrand, Preventive and Occupational Medicine, WittyFit, Université Clermont Auvergne, 63000 Clermont-Ferrand, France.
Faculty of Health, School of Exercise Science, Australian Catholic University, Melbourne, VIC 3000, Australia.

Vicky Drapeau (V)

Institute of Nutrition and Functional Foods (INAF), Université Laval, Québec, QC G0A 4V0, Canada.
Department of Physical Education, Université Laval, Québec, QC G1V 0A6, Canada.

Lore Metz (L)

Clermont Auvergne University, EA 3533, Laboratory of the Metabolic Adaptations to Exercise under Physiological and Pathological Conditions (AME2P), 63000 Clermont-Ferrand, France.
CRNH-Auvergne, 63000 Clermont-Ferrand, France.

Bruno Lesour (B)

CHU G. Montpied, F-63000 Clermont-Ferrand, France.

Robert Chapier (R)

Thermalia Center, F-63140 Châtelguyon, France.

Bruno Pereira (B)

Clermont-Ferrand University hospital, Biostatistics unit (DRCI), 63000 Clermont-Ferrand, France.

Julien Verney (J)

Clermont Auvergne University, EA 3533, Laboratory of the Metabolic Adaptations to Exercise under Physiological and Pathological Conditions (AME2P), 63000 Clermont-Ferrand, France.
CRNH-Auvergne, 63000 Clermont-Ferrand, France.

Julien S Baker (JS)

Institute of Clinical Exercise and Health Sciences, School of Science and Sport, University of the West of Scotland, Hamilton, Lanarkshire G72 0BN, Scotland, UK.

Agnes Vinet (A)

Avignon University LAPEC EA4278, F-84000 Avignon, France.

Guillaume Walther (G)

Avignon University LAPEC EA4278, F-84000 Avignon, France.

Philippe Obert (P)

Institute of Nutrition and Functional Foods (INAF), Université Laval, Québec, QC G0A 4V0, Canada.

Daniel Courteix (D)

Clermont Auvergne University, EA 3533, Laboratory of the Metabolic Adaptations to Exercise under Physiological and Pathological Conditions (AME2P), 63000 Clermont-Ferrand, France.
CRNH-Auvergne, 63000 Clermont-Ferrand, France.

David Thivel (D)

Clermont Auvergne University, EA 3533, Laboratory of the Metabolic Adaptations to Exercise under Physiological and Pathological Conditions (AME2P), 63000 Clermont-Ferrand, France.
CRNH-Auvergne, 63000 Clermont-Ferrand, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH